Brought to you by 
St. Jude Children's grants license to Insight Genetics
29 Mar 2021
Executive Summary
St. Jude Children's Research Hospital has granted Insight Genetics Inc. (molecular diagnostics for cancer) exclusive worldwide rights to IP regarding mutations in the anaplastic lymphoma kinase (ALK) gene, which Insight will use in the development of a new oncology test.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
St. Jude Children's grants license to Insight Genetics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice